PBD Biotech
PBD Biotech is developing phage-based diagnostics for mycobacteria to achieve the goals of the World Health Oraganization's "End TB Strategy".
Latest Content
Product News
Actiphage Enters New Clinical Trial Aimed at Early Tuberculosis Diagnosis
A new clinical trial of a ground-breaking phage-based molecular diagnostic, has been agreed. The trial is aimed at evaluating the performance of the phage assay as a first-line blood-based diagnostic for active pulmonary Tuberculosis.
Industry Insight
Exploiting Bacteriophage as a Diagnostic Tool
Technology Networks spoke to Dr. Tomas Richardson from PBD Biotech, to hear more about how bacteriophage can be used to diagnose tuberculosis in both humans and cattle.
Advertisement
